Published in AIDS Weekly, June 21st, 2004
The system, called Novacaps accommodates otherwise incompatible pharmaceutical agents, solid or liquid, in a single-dosage, combination product. Increased interest in such combination formats is evidenced by the FDA's recent initiative to advance the development of single-dosage forms for delivery of multiple HIV/AIDS drugs.
With this system, therapeutic entities that have never been combined before can be administered together, via an oral or a suppository capsule. This approach can not only maximize bioavailability but also can...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.